Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism

Medtronic’s revenue of $6.5bn in the first quarter of fiscal 2021 represents a 17% fall year-over-year, but it still beat analysts’ projections.

Medtronic-HQ_1200x675

Medtronic plc is focused on becoming more competitive even as it manages the recovery from the pandemic.

“We're playing offense and we're energized to use this moment when our pipeline is kicking in, to expand our markets and take share, and importantly, we're driving towards faster and broader top line growth, not just as we emerge from the pandemic, but sustainable

More from Cardiology

More from Device Area